Korsana Biosciences, Inc. Common Stock (KRSA) Stock Price

KRSAStock

$32.25

Market Cap$1.47B

P/E—

PEG Ratio—

Div yield—

Beta—

KRSA Share Price Chart

Favorite Metrics

VGM Score28.86

KRSA Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q1 2026	Jun 9, 2026	—	-$2.70	—
Q4 2025	Mar 31, 2026	-$0.38	-$0.19	+50.00%(+$0.19)
Q3 2025	Nov 12, 2025	—	-$0.30	—

Industry Peers — Pharmaceuticals(573)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth TTM (YoY)	Gross Margin (TTM)	EPS Growth (5Y)	Price
KRSAKorsana Biosciences, Inc. Common Stock	—	—	D	—	—	—	—	$32.25
LLYEli Lilly & Co.	D	B	B	14.0x	49.6%	83.4%	27.6%	$1182.24
JNJJohnson & Johnson	D	C	B	6.7x	8.1%	68.0%	14.9%	$267.29
ABBVABBVIE INC.	D	C	B	7.3x	10.4%	72.8%	-2.9%	$263.59
MRKMerck & Co., Inc.	D	C	A	5.5x	4.6%	77.3%	21.2%	$148.59
NVSNovartis AG	C	C	B	4.7x	3.3%	75.0%	15.3%	$145.03
AZNAstraZeneca PLC	C	B	C	4.2x	8.6%	81.3%	21.9%	$164.15
ABTAbbott Laboratories	C	C	C	3.7x	8.1%	56.8%	8.2%	$100.17
NVONovo-Nordisk A/S	B	C	C	3.4x	5.6%	80.7%	20.7%	$38.16
PFEPfizer Inc.	C	D	B	2.6x	-0.2%	74.7%	-3.5%	$28.53
VRTXVertex Pharmaceuticals Inc	D	C	B	10.6x	10.2%	86.0%	8.3%	$525.96
BMYBristol-Myers Squibb Co.	B	B	B	2.6x	3.1%	71.7%	—	$63.42
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	2.2x	5.0%	73.6%	-0.5%	$49.09
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	D	C	1.8x	13.4%	72.8%	-8.2%	$40.54
REGNRegeneron Pharmaceuticals Inc	C	C	B	5.0x	9.3%	86.0%	6.3%	$752.21
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	B	2.1x	3.1%	65.5%	-12.6%	$18.51
TEVATeva Pharmaceutical Industries Limited	D	C	B	2.6x	4.1%	52.9%	—	$39.92
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	B	6.4x	31.1%	88.5%	—	$364.08
ALNYAlnylam Pharmaceuticals, Inc.	D	A	C	7.0x	95.1%	79.7%	—	$252.37
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	13.2x	10.0%	—	-12.1%	$58.25
ZTSZOETIS INC.	B	C	D	3.0x	1.4%	71.6%	12.0%	$70.52
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	3546.4x	-67.6%	81.2%	—	$36.03
INSMInsmed, Inc.	F	A	C	22.6x	185.8%	83.5%	—	$115.76
GMABGenmab A/S ADS	C	C	B	5.0x	22.3%	93.0%	6.8%	$35.45
VTRSViatris Inc. Common Stock	B	C	A	1.4x	4.4%	40.3%	—	$17.89
UTHRUnited Therapeutics Corp	C	C	C	6.5x	2.5%	86.1%	19.3%	$477.80
JAZZJazz Pharmaceuticals, Inc.	B	C	B	3.3x	12.6%	88.4%	-1.4%	$229.80
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	11.8x	113.3%	91.3%	—	$226.67
BBIOBridgeBio Pharma, Inc. Common Stock	D	A	C	18.2x	202.4%	94.4%	—	$66.83
SMMTSummit Therapeutics Inc. Common Stock	F	—	C	12863.7x	—	—	—	$16.25
CORTCorcept Therapeutics Inc.	F	C	A	15.0x	16.0%	98.3%	-0.5%	$115.75
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	B	9.3x	149.0%	91.5%	—	$509.02
BMRNBioMarin Pharmaceuticals Inc	C	C	B	3.4x	11.2%	79.6%	-17.0%	$59.49
ELANElanco Animal Health Incorporated Common Stock	C	B	C	2.2x	11.9%	55.4%	29.9%	$22.43
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	3.0x	-0.9%	61.4%	-15.6%	$12.86
AXSMAxsome Therapeutics, Inc	D	B	C	13.3x	56.9%	93.2%	—	$183.38
ARWRArrowhead Research Corporation	D	A	B	13.8x	16.9%	—	—	$65.75
PTGXProtagonist Therapeutics, Inc	F	B	A	32.5x	34.8%	—	—	$139.93
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	213.8x	2928.4%	—	—	$84.95
CYTKCytokinetics Inc.	F	D	C	135.1x	-21.1%	—	—	$64.58
TGTXTG Therapeutics, Inc.	D	B	B	11.0x	76.1%	82.4%	—	$55.96
ABVXAbivax SA American Depositary Shares	—	—	C	—	—	—	—	$98.14
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	C	932.5x	—	—	—	$280.35
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	D	8.8x	-7.5%	98.2%	—	$45.88
SYRESpyre Therapeutics, Inc. Common Stock	—	—	B	6185.8x	—	—	—	$84.28
AMRXAmneal Pharmaceuticals, Inc. Class A Common Stock	D	C	A	2.1x	9.3%	39.3%	-18.4%	$20.21
ALKSAlkermes Inc. plc	D	C	C	4.1x	10.8%	84.6%	—	$40.11
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	—	—	—	—	$165.38
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	28.0x	53.5%	70.9%	—	$96.70
LQDALiquidia Corporation Common Stock	D	A	B	14.6x	2233.7%	92.6%	—	$70.00
LGNDLigand Pharmaceuticals Inc.	D	B	B	20.6x	54.9%	95.4%	—	$305.63

About Korsana Biosciences, Inc. Common Stock

Korsana Biosciences Inc is a biopharmaceutical company developing therapeutics to treat neurodegenerative diseases beginning with Alzheimer's disease (AD. The company's flagship product candidate, KRSA-028, is an anti-amyloid beta antibody that combines the proprietary Therapeutic Targeting (THETA) platform with well-validated aspects from other anti-Ab products that have achieved regulatory approval or are in late-stage clinical trials.